Cassandra Slader
Impact in
- Hematology top 1%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 12
- Chronic Myeloid Leukemia Treatments 12
- Genetics 11
- Chronic Lymphocytic Leukemia Research 10
- Co-authors
- Timothy P. Hughes (11 shared papers)David M. Ross (5 shared papers)Anthony P. Schwarer (6 shared papers)Susan Branford (6 shared papers)Christopher Arthur (6 shared papers)Anthony K. Mills (7 shared papers)Andrew Grigg (8 shared papers)Robin Filshie (5 shared papers)
- Journals
- Blood (8 papers)Journal of Pharmacy Practice and Research (2 papers)Annals of Hematology (1 paper)Haematologica (1 paper)Journal of Cancer Research and Clinical Oncology (1 paper)
- Partner nations
- AustraliaSwitzerlandNew Zealand
In The Last Decade
Cassandra Slader
19 papers receiving 1.0k citations
Cassandra Slader's Hit Papers
Peers
Comparison fields: 5 of 73
- Hematology 787
- Genetics 540
- Rheumatology 330
- Complementary and alternative medicine 62
- Pathology and Forensic Medicine 80
Countries citing papers authored by Cassandra Slader
This map shows the geographic impact of Cassandra Slader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cassandra Slader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cassandra Slader more than expected).
Fields of papers citing papers by Cassandra Slader
This network shows the impact of papers produced by Cassandra Slader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cassandra Slader. The network helps show where Cassandra Slader may publish in the future.
Co-authors
The 25 scholars most cited alongside Cassandra Slader, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study Hit paper breakdown → | 2013 | 512 |
| 2 | 2010 | 196 | |
| 3 | 2006 | 115 | |
| 4 | 2006 | 65 | |
| 5 | 2011 | 44 | |
| 6 | 2020 | 35 | |
| 7 | 2011 | 23 | |
| 8 | 2012 | 14 | |
| 9 | 2010 | 9 | |
| 10 | 2004 | 5 | |
| 11 | 2005 | 4 | |
| 12 | 2023 | 4 | |
| 13 | 2009 | 4 | |
| 14 | 2010 | 3 | |
| 15 | 2021 | 2 | |
| 16 | 2011 | 1 | |
| 17 | 2003 | 1 | |
| 18 | 2011 | 1 | |
| 19 | 2018 | 1 | |
| 20 | 2003 | 0 |
About Cassandra Slader
Cassandra Slader is a scholar working on Hematology, Genetics, Public Health, Environmental and Occupational Health, Rheumatology and Pulmonary and Respiratory Medicine, having authored 20 papers that have together received 1.0k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (12 papers), Chronic Lymphocytic Leukemia Research (10 papers), Acute Lymphoblastic Leukemia research (4 papers), Eosinophilic Disorders and Syndromes (4 papers), Lymphoma Diagnosis and Treatment (2 papers), Pharmaceutical Practices and Patient Outcomes (1 paper), Eicosanoids and Hypertension Pharmacology (1 paper) and Patient Safety and Medication Errors (1 paper). The work is most often cited by research in Hematology (787 citations), Genetics (540 citations), Rheumatology (330 citations), Complementary and alternative medicine (62 citations) and Pathology and Forensic Medicine (80 citations). Cassandra Slader has collaborated with scholars based in Australia, Switzerland and New Zealand. Frequent co-authors include Timothy P. Hughes, David M. Ross, Anthony P. Schwarer, Susan Branford, Christopher Arthur, Anthony K. Mills, Andrew Grigg, Robin Filshie, John F. Seymour and Deborah L. White. Their work appears in journals such as Blood, Journal of Pharmacy Practice and Research, Annals of Hematology, Haematologica and Journal of Cancer Research and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.